Also, small-molecule compounds that interfere with the EED/EZH2 interaction have been developed (e.g., astemizole and DC-PRC2in-01) and tested in PRC2-dependent follicular lymphomas (Du et al., 2021). The gene discussed is EZH2; the disease is follicular lymphoma.